February 01, 2011

AIPLA Mid-Winter Institute

Myriad & DNA Patents: Are Standards Changing Around the World?

Overview

Washington, D.C., partner Mercedes Meyer presented to the Japan Practice Committee at the American Intellectual Property Law Association’s Mid-Winter Institute, held February 2-5, 2011, in Orlando, Fla.  The event featured speakers from the Japan and U.S.   

 

The talk emphasized the increasing hostility of governments and entities world wide to gene patents because of misconceived understandings of the importance of patents to the advancement of technology.  The Myriad case focuses in on whether gene patents are patent eligible subject matter.  In the U.S., the Department of Justice and White House are attacking the eligibility of these patents and their position differs from the U.S. Patent and Trademark Office.  Mercedes, a partner in the Intellectual Property Practice Group, discussed how a similar attack is now occurring in Australia in legislation contemplated in the Australian Senate.

Services and Industries

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.